阿肯色州 的 转移性癌症 临床试验
阿肯色州 有 14 项针对 转移性癌症 的研究正在招募参与者。
阿肯色州 的城市
官方研究文本（英文）
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro, Jonesboro
招募中2 期
所有年龄段 · 所有性别 · 更新于 2026年9月29日 · NCT05564377Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- Highlands Oncology Group, Fayetteville
- Highlands Oncology Group, Rogers
- Highlands Oncology Group, Springdale
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月28日 · NCT07222800A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
- University of Arkansas Medical School, Little Rock
招募中1 期
19 岁及以上 · 所有性别 · 更新于 2026年9月28日 · NCT06586957A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- Central Arkansas Radiation Therapy Institute, dba CARTI, Bryant
- Central Arkansas Radiation Therapy Institute, dba CARTI, Conway
- CARTI Cancer Center, Little Rock
- 以及另外 2 项
招募中2/3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月25日 · NCT06989437Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- Highlands Oncology Group, Fayetteville
- Highlands Oncology Group, Rogers
- Highlands Oncology Group, Springdale
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月25日 · NCT07222566A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
- Research Site, Springdale
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月25日 · NCT06103864A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
- University of Arkansas for Medical Sciences, Little Rock
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月22日 · NCT07218380A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
- Genesis Cancer and Blood Institute, Hot Springs
- Highlands Oncology Group, Springdale
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月22日 · NCT07174336Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
- Highlands Oncology Group, Fayetteville
- Highlands Oncology Group, Rogers
- Highlands Oncology Group, PA, Springdale
招募中1/2 期
18 岁及以上 · 所有性别 · 更新于 2026年9月17日 · NCT07227415A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Highlands Oncology Group, Springdale
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月8日 · NCT06119581A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- University of Arkansas - Winthrop P. Rockefeller Cancer Institute, Little Rock
招募中1/2 期
18 岁及以上 · 所有性别 · 更新于 2026年7月30日 · NCT04657068Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
- Genesis Cancer and Blood Institute, Hot Springs
招募中2/3 期
18 岁及以上 · 所有性别 · 更新于 2026年5月8日 · NCT06697301Collection and Storage of Tissue and Blood Samples From Patients With Cancer
- Mercy Hospital Fort Smith, Fort Smith
招募中观察性研究
2 Months · 所有性别 · 更新于 2026年3月5日 · NCT02474160SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Little Rock
招募中观察性研究
所有年龄段 · 所有性别 · 更新于 2025年10月28日 · NCT03452774数据来自 ClinicalTrials.gov，检索日期：2026年10月1日。每项研究自行设定入选标准，由研究团队决定谁能参与。